Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion type Assertion NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_head.
- NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion description "[This study provides the first evidence for an oncogenic activity of miR-155, miR-203, miR-210 and miR-222 in the development of pancreatic cancer as has been reported for other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_provenance.
- NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion evidence source_evidence_literature NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_provenance.
- NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion SIO_000772 19551852 NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_provenance.
- NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion wasDerivedFrom befree-2016 NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_provenance.
- NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_assertion wasGeneratedBy ECO_0000203 NP747263.RAgNVBbbY9f2Qp9ern5Fh7VXkkQuxw9s7BY7nnhHEmf00130_provenance.